1.
Chaokhamin I, Attawettayanon W, Chalieopanyarwong V, Tanthanuch M, Bejrananda T. Oncological outcomes of metastatic castration resistant prostate cancer (mCRPC) treated with different therapies sequences after completion of docetaxel: a retrospective study in Songklanagarind Hospital. Insight Urol [Internet]. 2021 Nov. 30 [cited 2024 May 28];42(2):131-7. Available from: https://he02.tci-thaijo.org/index.php/TJU/article/view/250553